Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARTERIAL VASCULAR ENGINEERING -- Ignore unavailable to you. Want to Upgrade?

To: Jeff Gurian who wrote (321)	12/26/1997 2:12:00 PM
From: Zeus549	Respond to of 339

Jeff, as I've stated a couple of times recently, I think a great deal of the FDA approval and a lot of earnigns are already in the current price. I think the thing to do is a little math to figue out where the current price is on PE basis and what kind of earrnings expectation that it is already reflecting. See what you come up with.IMO on a TA basis, the charts are not and have not been looking real strong ever since their first flurry into the 60's. I sold a little too soon, but thats the way it goes. Have a Happy (and Prosperous) New Year.

To: Jeff Gurian who wrote (321)	12/26/1997 7:06:00 PM
From: B4TheBell	Read Replies (2) \| Respond to of 339

Jeff, I have Guidant's earnings as coming out the first week of February, the 3rd I think, but they may be early. I think AVEI will benefit by association, but as you said, it won't really begin until next quarter, about April timeframe. B4